CCND1 and neoplasm: It was selected for subsequent analysis as a tumour suppressive role of miR-449a has been suggested in a number of malignancies [16–19], most notably in prostate cancer by targeting classical proto-oncogenes CCND1 [20], c-Myc [21] and HDAC-1 [22].